SANOFI AVENTIS US FDA Approval NDA 020707

NDA 020707

SANOFI AVENTIS US

FDA Drug Application

Application #020707

Documents

Letter2006-11-22
Label2006-11-22
Other Important Information from FDA2008-01-07
Letter2003-08-28
Letter2010-03-24
Label2010-03-26
Review2010-01-05

Application Sponsors

NDA 020707SANOFI AVENTIS US

Marketing Status

Discontinued001

Application Products

001TABLET;ORALEQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1SKELIDTILUDRONATE DISODIUM

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1997-03-07STANDARD
LABELING; LabelingSUPPL4AP2003-08-21STANDARD
LABELING; LabelingSUPPL5AP2006-11-17STANDARD
LABELING; LabelingSUPPL6AP2010-03-19STANDARD

Submissions Property Types

ORIG1Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20707
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.